Henry Schein, Inc. (NASDAQ:HSIC) Receives $79.30 Average Price Target from Analysts

Henry Schein, Inc. (NASDAQ:HSIC - Get Free Report) has been given a consensus rating of "Moderate Buy" by the eleven analysts that are covering the company, Marketbeat Ratings reports. Five investment analysts have rated the stock with a hold recommendation, five have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is $79.30.

A number of research analysts have issued reports on HSIC shares. UBS Group reduced their price target on Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a research report on Wednesday, February 26th. Piper Sandler decreased their target price on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating for the company in a research report on Wednesday, April 30th. Wall Street Zen downgraded shares of Henry Schein from a "buy" rating to a "hold" rating in a research report on Thursday, April 17th. Wells Fargo & Company reduced their price target on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a research note on Tuesday, May 6th. Finally, Barrington Research lowered their price objective on shares of Henry Schein from $90.00 to $86.00 and set an "outperform" rating on the stock in a research note on Tuesday, May 6th.

Henry Schein Stock Performance

Henry Schein stock traded up $0.47 during midday trading on Tuesday, reaching $71.37. 971,633 shares of the stock traded hands, compared to its average volume of 1,681,971. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The firm has a fifty day moving average price of $67.80 and a two-hundred day moving average price of $71.57. The firm has a market cap of $8.69 billion, a price-to-earnings ratio of 29.37, a PEG ratio of 2.13 and a beta of 0.86. Henry Schein has a fifty-two week low of $60.56 and a fifty-two week high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings results on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, beating analysts' consensus estimates of $1.11 by $0.04. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company had revenue of $3.17 billion for the quarter, compared to analysts' expectations of $3.24 billion. During the same quarter in the previous year, the company posted $1.10 earnings per share. The business's revenue for the quarter was down .1% compared to the same quarter last year. On average, equities research analysts forecast that Henry Schein will post 4.74 earnings per share for the current year.

Insiders Place Their Bets

In other Henry Schein news, CEO Bradford C. Connett sold 4,036 shares of the company's stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total transaction of $287,161.40. Following the completion of the sale, the chief executive officer now directly owns 62,688 shares of the company's stock, valued at approximately $4,460,251.20. This represents a 6.05% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Philip A. Laskawy sold 2,604 shares of the business's stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the sale, the director now owns 24,805 shares in the company, valued at $1,762,147.20. This represents a 9.50% decrease in their position. The disclosure for this sale can be found here. 1.08% of the stock is currently owned by company insiders.

Institutional Trading of Henry Schein

Several large investors have recently added to or reduced their stakes in HSIC. Strs Ohio purchased a new position in shares of Henry Schein during the first quarter valued at $1,859,000. Acadian Asset Management LLC acquired a new stake in Henry Schein during the 1st quarter worth about $676,000. IFM Investors Pty Ltd boosted its position in Henry Schein by 6.6% during the 1st quarter. IFM Investors Pty Ltd now owns 23,831 shares of the company's stock worth $1,737,000 after acquiring an additional 1,482 shares during the period. Focus Partners Wealth grew its stake in Henry Schein by 1.8% during the 1st quarter. Focus Partners Wealth now owns 32,241 shares of the company's stock valued at $2,208,000 after acquiring an additional 560 shares in the last quarter. Finally, Bayforest Capital Ltd acquired a new position in shares of Henry Schein in the 1st quarter valued at about $103,000. 96.62% of the stock is owned by institutional investors and hedge funds.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.